Skeletal Muscle Mitochondrial Functions, Mitochondrial DNA Copy Numbers, and Gene Transcript Profiles in Type 2 Diabetic and Nondiabetic Subjects at Equal Levels of Low or High Insulin and Euglycemia
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
We investigated whether previously reported muscle mitochondrial dysfunction and altered gene transcript levels in type 2 diabetes might be secondary to abnormal blood glucose and insulin levels rather than an intrinsic defect of type 2 diabetes. A total of 13 type 2 diabetic and 17 nondiabetic subjects were studied on two separate occasions while maintaining similar insulin and glucose levels in both groups by 7-h infusions of somatostatin, low- or high-dose insulin (0.25 and 1.5 mU/kg of fat-free mass per min, respectively), and glucose. Muscle mitochondrial DNA abundance was not different between type 2 diabetic and nondiabetic subjects at both insulin levels, but the majority of transcripts in muscle that are involved mitochondrial functions were expressed at lower levels in type 2 diabetes at low levels of insulin. However, several gene transcripts that are specifically involved in the electron transport chain were expressed at higher levels in type 2 diabetic patients. After the low-dose insulin infusion, which achieved postabsorptive insulin levels, the muscle mitochondrial ATP production rate (MAPR) was not different between type 2 diabetic and nondiabetic subjects. However, increasing insulin to postprandial levels increased the MAPR in nondiabetic subjects but not in type 2 diabetic patients. The lack of MAPR increment in response to high-dose insulin in type 2 diabetic patients occurred in association with reduced glucose disposal and expression of peroxisome proliferator–activated receptor-γ coactivator 1α, citrate synthase, and cytochrome c oxidase I. In conclusion, the current data supports that muscle mitochondrial dysfunction in type 2 diabetes is not an intrinsic defect, but instead a functional defect related to impaired response to insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This hypothesis is based on the finding that type 2 diabetics and insulin-resistant individuals with impaired glucose tolerance have ≈30% less mitochondria in their muscles than insulin-sensitive control subjects (3–7).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [6]
In the citing paper
“In some studies, surrogate markers of mitochondrial content are reduced (7, 9, 14), whereas in others they are not (15, 16).”
In the citing paper
“Insulin resistance was associated with less mtDNA in some studies (9, 14) but not in others (15).”
In the citing paper
“Thus, studies which have assessed mitochondrial copy number in skeletal muscle in insulin-resistant individuals have reported conflicting results [114–116].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [116]
In the citing paper
“it has been shown that insulin can stimulate mitochondrial biogenesis and increases ATP synthesis in skeletal muscle (6,7).”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [7]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Southgate, R. J., Bruce, C. R., Carey, A. L., Steinberg, G. R., Walder, K., Monks, R., Watt, M. J., Hawley, J. A., Birnbaum, M. J., & Febbraio, M. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3993fje · Cited by 74
RetractedMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 3×
“(21) performed analysis after a 2-h hyperinsulinemic clamp.”
BackgroundMethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
A questionnaire for the assessment of leisure time physical activities
Taylor, H. L., Jacobs, D. R., Schucker, B., Knudsen, J., Leon, A. S., & Debacker, G. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90058-9 · Cited by 1,848
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
Decline in skeletal muscle mitochondrial function with aging in humans
Short, K. R., Bigelow, M. L., Kahl, J., Singh, R., Coenen-Schimke, J., Raghavakaimal, S., & Nair, K. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501559102 · Cited by 1,333
Self-citationLow-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Insulin Action and the Insulin Signaling Network*
CHEATHAM, B., & KAHN, C. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-117 · Cited by 881
Doniger, S. W., Salomonis, N., Dahlquist, K. D., Vranizan, K., Lawlor, S. C., & Conklin, B. R. (2003) · Genome Biology · doi:10.1186/gb-2003-4-1-r7 · Cited by 865
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566
Regulation of gene expression by insulin
O'Brien, R. M., & Granner, D. K. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.4.1109 · Cited by 540
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534
Stump, C. S., Short, K. R., Bigelow, M. L., Schimke, J. M., & Nair, K. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332551100 · Cited by 477
Self-citationZhang, B., Schmoyer, D., Kirov, S., & Snoddy, J. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-16 · Cited by 450
Barazzoni, R., Short, K. R., & Nair, K. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3343 · Cited by 367 · cited 1×
“Similar mtDNA abundance in type 2 diabetic and nondiabetic subjects observed in the current study is in contrast with an age-related decrease in mtDNA abundance reported in skeletal muscle of humans (13) and rodents (34).”
ResultSelf-citationMinn, A. H., Hafele, C., & Shalev, A. (2005) · Endocrinology · doi:10.1210/en.2004-1378 · Cited by 367
WU, P., SATO, J., ZHAO, Y., JASKIEWICZ, J., POPOV, M. K., & HARRIS, A. R. (1998) · Biochemical Journal · doi:10.1042/bj3290197 · Cited by 310
Regulation of gene expression by insulin
O'Brien, R. M., & Granner, D. K. (1991) · Biochemical Journal · doi:10.1042/bj2780609 · Cited by 285
Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
Sreekumar, R., Halvatsiotis, P., Schimke, J. C., & Nair, K. S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1913 · Cited by 257 · cited 4×
“However, these studies were carried out either under postabsorptive states, when blood glucose and insulin levels were significantly higher in diabetic subjects compared with nondiabetic subjects (20,22), or after a short period (2 h) of euglycemic-hyperinsulinemic clamp, where the blood insulin levels may not be simi…”
BackgroundResultInfluentialSelf-citationAge effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise
Balagopal, P., Schimke, J. C., Ades, P., Adey, D., & Nair, K. S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e203 · Cited by 247
Self-citationHuang, B., Wu, P., Bowker-Kinley, M. M., & Harris, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.276 · Cited by 246
Rieusset, J., Bouzakri, K., Chevillotte, E., Ricard, N., Jacquet, D., Bastard, J.-P., Laville, M., & Vidal, H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2232 · Cited by 200
Rome, S., Clément, K., Rabasa-Lhoret, R., Loizon, E., Poitou, C., Barsh, G. S., Riou, J.-P., Laville, M., & Vidal, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300293200 · Cited by 187
Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha.
Hwang, C. S., Mandrup, S., MacDougald, O. A., Geiman, D. E., & Lane, M. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.873 · Cited by 185
Substrate and Energy Metabolism in Man
Garrow, J. S., & Halliday, D. (1985) · Medical Entomology and Zoology · Cited by 181
Ravussin, E., Bogardus, C., Schwartz, R. S., Robbins, D. C., Wolfe, R. R., Horton, E. S., Danforth, E., & Sims, E. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111060 · Cited by 172 · cited 1×
“It is also known that oxygen consumption or thermic response to oral glucose (35), intravenous glucose, and insulin infusions (36) is also lower in type 2 diabetic patients, which is consistent with the current observation of a lack of increase in MAPR in type 2 diabetic patients.”
ResultExperimental investigation of protein folding and misfolding
Dobson, C. M. (2004) · Methods · doi:10.1016/j.ymeth.2004.03.002 · Cited by 157
Tanis: A Link Between Type 2 Diabetes and Inflammation?
Walder, K., Kantham, L., McMillan, J. S., Trevaskis, J., Kerr, L., de Silva, A., Sunderland, T., Godde, N., Gao, Y., Bishara, N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1859 · Cited by 156
Engström, G., Stavenow, L., Hedblad, B., Lind, P., Eriksson, K.-F., Janzon, L., & Lindgärde, F. (2003) · Diabetes · doi:10.2337/diabetes.52.2.442 · Cited by 145
Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes
Halvatsiotis, P., Short, K. R., Bigelow, M., & Nair, K. S. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2395 · Cited by 143
Self-citationDecreased Plasma Lipoprotein Lipase in Hypoadiponectinemia
von Eynatten, M., Schneider, J. G., Humpert, P. M., Rudofsky, G., Schmidt, N., Barosch, P., Hamann, A., Morcos, M., Kreuzer, J., Bierhaus, A., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2925 · Cited by 138
Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin
Boirie, Y., Short, K. R., Ahlman, B., Charlton, M., & Nair, K. S. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2652 · Cited by 137
Self-citationRazak, F., & Anand, S. S. (2004) · Vascular Medicine · doi:10.1191/1358863x04vm568xx · Cited by 134
Antonetti, D. A., Reynet, C., & Kahn, C. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117790 · Cited by 122
Yang, X., Pratley, R. E., Tokraks, S., Bogardus, C., & Permana, P. A. (2002) · Diabetologia · doi:10.1007/s00125-002-0905-7 · Cited by 121
Neurofilament and tubulin gene expression in progressive experimental diabetes
Scott, J. N., Clark, A. W., & Zochodne, D. W. (1999) · Brain · doi:10.1093/brain/122.11.2109 · Cited by 110
Heated dorsal hand vein sampling for metabolic studies: a reappraisal
Copeland, K. C., Kenney, F. A., & Nair, K. S. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.5.e1010 · Cited by 96
Self-citationATP production rate in mitochondria isolated from microsamples of human muscle
Wibom, R., & Hultman, E. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.2.e204 · Cited by 84
Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels
Yamawaki, H., & Berk, B. C. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200503000-00010 · Cited by 84
Andersen, P. H. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.27 · Cited by 69
Andreelli, F., Laville, M., Ducluzeau, P.-H., Vega, N., Vallier, P., Khalfallah, Y., Riou, J.-P., & Vidal, H. (1999) · Diabetologia · doi:10.1007/s001250051163 · Cited by 60 · cited 1×
“In response to insulin infusion, the induction of gene transcripts encoding GLUT4 (6,7), insulin receptor substrate-1 and -2 (8), and p85 –phosphatidylinositol 3-kinase (9) is impaired in skeletal muscle of type 2 diabetic patients compared with nondiabetic subjects.”
BackgroundSampling the intramyocellular triglycerides from skeletal muscle
Guo, Z., Mishra, P., & Macura, S. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31592-3 · Cited by 58
Self-citationNair, K. S., Webster, J., & Garrow, J. S. (1986) · Metabolism · doi:10.1016/0026-0495(86)90171-x · Cited by 47
Self-citationSchalin-J�ntti, C., Yki-J�rvinen, H., Koranyi, L. I., Bourey, R. E., Lindstr�m, J., Nikula-Ijäs, P., Franssila-Kallunki, A., & Groop, L. (1994) · Diabetologia · doi:10.1007/bf00408478 · Cited by 39
Kropf, S., & Läuter, J. (2002) · Biometrical Journal · doi:10.1002/1521-4036(200210)44:7<789::aid-bimj789>3.0.co;2-# · Cited by 30
Rich, S. S., Bowden, D. W., Haffner, S. M., Norris, J. M., Saad, M. F., Mitchell, B. D., Rotter, J. I., Langefeld, C. D., Hedrick, C. C., Wagenknecht, L. E., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.290 · Cited by 25
Insulin therapy for type 2 diabetes
Sasali, A., & Leahy, J. L. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0081-2 · Cited by 13
Energy and protein metabolism in diabetes and obesity.
Nair, K. S. (1984) · Europe PMC (PubMed Central) · Cited by 12
Self-citationMir, A. A., Myakishev, M. V., Polesskaya, O., Moitra, J., Petersen, D. W., Miller, L. D., Orosz, A., & Vinson, C. (2003) · Genomics · doi:10.1016/s0888-7543(03)00024-7 · Cited by 11
Cited by
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
“[116] Y.”
ResultMitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials
Marzetti, E., Calvani, R., Cesari, M., Buford, T. W., Lorenzi, M., Behnke, B. J., & Leeuwenburgh, C. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.024 · Cited by 627
“Although mitochondrial decay has traditionally been attributed a causative role in insulin resistance, some intriguing findings point to impaired insulin sensitivity as a determinant of muscle mitochondrial dysfunction rather than the opposite (Stump et al. 2003; Asmann et al. 2006).”
Endurance Exercise as a Countermeasure for Aging
Lanza, I. R., Short, D. K., Short, K. R., Raghavakaimal, S., Basu, R., Joyner, M. J., McConnell, J. P., & Nair, K. S. (2008) · Diabetes · doi:10.2337/db08-0349 · Cited by 582
“It has been proposed that mitochondrial dysfunction plays an etiological role in the development of insulin resistance (11,40), while some evidence supports an alternative hypothesis that mitochondrial dysfunction may result from insulin resistance (41,42).”
BackgroundSelf-citationHigh-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538
“If increases in FFA do not mediate a decrease in mitochondria, what is responsible for the lower than usual amount of mitochondria in skeletal muscle of insulin-resistant patients? Nair and coworkers (6) have hypothesized that, rather than causing insulin resistance, a reduction in mitochondrial content is mediated by…”
BackgroundMitochondrial dysfunction and insulin resistance: an update
Montgomery, M. K., & Turner, N. (2015) · Endocrine Connections · doi:10.1530/ec-14-0092 · Cited by 527
“This direct effect of insulin on mitochondrial function is diminished in subjects with IR (60) and in rats after high-fat feeding (63), suggesting that insulin is able to activate mitochondrial biogenesis and oxidative capacity, and that IR, particularly if it is present over a prolonged period,…”
Background
Metadata
- Authors
- Asmann, Y. W., Stump, C. S., Short, K. R., Coenen-Schimke, J. M., Guo, Z., Bigelow, M. L., & Nair, K. S.
- Affiliations
- Mayo Clinic (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 55
- Issue
- 12
- Pages
- 3309-3319
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2097286914
- Cited by
- 207
- References
- 58
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 12 · 2022: 4 · 2021: 10 · 2020: 10 · 2019: 9 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 15 · 2012: 16
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK41972, T32 DK7352-25, T32DK007352)
- National Center for Research Resources (M01-RR00 585, M01RR000585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- type 2 diabetes, skeletal muscle mitochondria, mitochondrial dysfunction, mitochondrial DNA copy number, insulin sensitivity, insulin resistance, mitochondrial gene expression, electron transport chain, glucose disposal, PGC-1α, citrate synthase, cytochrome c oxidase I, normoglycemia
- MeSH terms
- Biopsy, Blood Glucose, Diabetes Mellitus, Type 2, DNA, Mitochondrial, Humans, Infusions, Intravenous, Insulin, Middle Aged, Mitochondria, Muscle, Reference Values, Transcription, Genetic, Body Mass Index, Muscle, Skeletal, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.